1. Associations between tumor vascularization assessed by in vivo DCE‐MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis. Issue 6 (27th January 2014) Authors: Nilsen, Line B.; Fangberget, Anne; Geier, Oliver M.; Engebraaten, Olav; Borgen, Elin; Olsen, Dag Rune; Seierstad, Therese Journal: Journal of magnetic resonance imaging Issue: Volume 40:Issue 6(2014) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer. (1st January 2020) Authors: Tinholt, Mari; Stavik, Benedicte; Tekpli, Xavier; Garred, Øystein; Borgen, Elin; Kristensen, Vessela; Sahlberg, Kristine Kleivi; Sandset, Per Morten; Iversen, Nina Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. (September 2021) Authors: Hartkopf, Andreas D.; Brucker, Sara Y.; Taran, Florin-Andrei; Harbeck, Nadia; von Au, Alexandra; Naume, Bjørn; Pierga, Jean-Yves; Hoffmann, Oliver; Beckmann, Matthias W.; Rydén, Lisa; Fehm, Tanja; Aft, Rebecca; Solà, Montserrat; Walter, Vincent; Rack, Brigitte; Schuetz, Florian; Borgen, Elin; Ta,... Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DNA methylation at enhancers identifies distinct breast cancer lineages. Issue 1 (December 2017) Authors: Fleischer, Thomas; Tekpli, Xavier; Mathelier, Anthony; Wang, Shixiong; Nebdal, Daniel; Dhakal, Hari; Sahlberg, Kristine; Schlichting, Ellen; Børresen-Dale, Anne-Lise; Borgen, Elin; Naume, Bjørn; Eskeland, Ragnhild; Frigessi, Arnoldo; Tost, Jörg; Hurtado, Antoni; Kristensen, Vessela Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer. Issue 9 (18th June 2020) Authors: von der Lippe Gythfeldt, Hedda; Lien, Tonje; Tekpli, Xavier; Silwal‐Pandit, Laxmi; Borgen, Elin; Garred, Øystein; Skjerven, Helle; Schlichting, Ellen; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Kristensen, Vessela; Børresen‐Dale, Anne‐Lise; Lingjærde, Ole Christian; Engebraaten, Olav Journal: International journal of cancer Issue: Volume 147:Issue 9(2020) Page Start: 2515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Issue 4 (14th December 2020) Authors: Helland, Thomas; Naume, Bjørn; Hustad, Steinar; Bifulco, Ersilia; Kvaløy, Jan Terje; Sætersdal, Anna Barbro; Synnestvedt, Marit; Lende, Tone Hoel; Gilje, Bjørnar; Mjaaland, Ingvil; Weyde, Kjetil; Blix, Egil Støre; Wiedswang, Gro; Borgen, Elin; Hertz, Daniel Louis; Janssen, Emiel Adrianus Maria; M... Journal: Molecular oncology Issue: Volume 15:Issue 4(2021) Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers. (2021) Authors: Haugen, Mads H.; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin; Loman, Niklas; Hatschek, Thomas; Børresen-Dale, Anne-Lise; Naume, Bjørn; Mills, Gordon B.; Mælandsmo, Gunhild M.; Engebraaten, Olav Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum levels of inflammation‐related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. Issue 1 (8th October 2019) Authors: Nome, Marianne E.; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone F.; Giskeødegård, Guro F.; Taskén, Kristin A.; Mælandsmo, Gunhild M.; Halvorsen, Bente; Yndestad, Arne; Borgen, Elin; Garred, Øystein; Aukrust, Pål; Ueland, Thor; Engebraaten, Olav; Kristensen, Vessela N.; Tekpli, X... Journal: International journal of cancer Issue: Volume 146:Issue 1(2020) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Issue 1 (December 2016) Authors: Demeulemeester, Jonas; Kumar, Parveen; Møller, Elen; Nord, Silje; Wedge, David; Peterson, April; Mathiesen, Randi; Fjelldal, Renathe; Zamani Esteki, Masoud; Theunis, Koen; Fernandez Gallardo, Elia; Grundstad, A.; Borgen, Elin; Baumbusch, Lars; Børresen-Dale, Anne-Lise; White, Kevin; Kristensen, V... Journal: Genome biology Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗